Patient Safety Tool: MRSA Evaluation and Treatment Guide
According to the CDC, incision and drainage is the primary therapy for MRSA infections. Empiric antimicrobial coverage for MRSA may be warranted in addition to incision and drainage based on clinical assessment. Antibiotic treatment, if indicated, should be guided by the susceptibility profile of the organism. Obtaining specimens for culture and susceptibility testing is useful to guide therapy, particularly for those with more severe infections and those who fail to respond adequately to initial management.
MRSA skin infections can develop into more serious infections. It is important to discuss a follow-up plan with patients in case they develop systemic symptoms or worsening local symptoms or if symptoms do not improve within 48 hours.
To download the document, click here (pdf).
Download other patient safety-related tools and resources:
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- Anthem is 1st payer to challenge DOJ lawsuit: 5 takeaways
- Medical errors occur in nearly 50% of surgeries: 4 key notes
- Did the ACA actually lower premiums? 5 observations
- Boston University to increase dermatologists practicing in academia: 5 takeaways from the new residency program
- 30 things for ASC leaders to know for July